Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;101:40-49
Published online before print May 31, 2007, doi: 10.1161/CIRCRESAHA.106.135814
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
101/1/40    most recent
CIRCRESAHA.106.135814v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontaine, C.
Right arrow Articles by Chinetti-Gbaguidi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontaine, C.
Right arrow Articles by Chinetti-Gbaguidi, G.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Gene regulation
Right arrow Receptor pharmacology
(Circulation Research. 2007;101:40.)
© 2007 American Heart Association, Inc.


Molecular Medicine

Liver X Receptor Activation Potentiates the Lipopolysaccharide Response in Human Macrophages

Coralie Fontaine*, Elena Rigamonti*, Atsushi Nohara, Philippe Gervois, Elisabeth Teissier, Jean-Charles Fruchart, Bart Staels, Giulia Chinetti-Gbaguidi

From the Institut Pasteur de Lille, Département d’Athérosclérose, Lille; Inserm U545, Lille; and Université de Lille 2, Faculté de Pharmacie, Lille, France.

Correspondence to Bart Staels, Inserm U545, Institut Pasteur de Lille, 1, rue du Professeur Calmette, BP 245, Lille 59019, France. E-mail Bart.Staels{at}pasteur-lille.fr

Macrophages play a central role in host defense against pathogen microbes by recognizing bacterial components, resulting in the activation of an arsenal of anti-microbial effectors. Toll-like receptor (TLR)-4 mediates the recognition of lipopolysaccharide, a pathogen-associated molecular pattern from Gram-negative bacteria. Activation of the TLR-4 signaling pathway by lipopolysaccharide increases antibacterial effects by inducing secretion of cytokines that activate an immune inflammatory response and by generating bactericidal reactive oxygen species via the NADPH oxidase system. Liver X Receptors (LXRs) are nuclear receptors controlling cholesterol homeostasis and inflammation in macrophages. In addition, LXRs are critical for macrophage survival and play a role in the innate immune response in the mouse. In this study, we investigated whether LXR activation also regulates host defense mechanisms in human macrophages. In primary human macrophages, oxidized LDL and synthetic LXR ligands increased TLR-4 gene expression. Transient transfection assays, gel shift and chromatin immunoprecipitation analysis indicated that LXRs induce human TLR-4 promoter activity by binding to a DR4-type LXR response element. LXR induction of TLR-4 mRNA was followed by an induction of TLR-4 protein expression. Moreover, although short-term pretreatment with LXR agonists significantly reduced the inflammatory response induced by lipopolysaccharide, pretreatment of macrophages for 48 hours with LXR agonists resulted in an enhanced lipopolysaccharide response. Finally, LXR activation increased reactive oxygen species generation by enhancing the expression of NADPH oxidase subunits. These data provide evidence for an immunomodulatory function of LXRs in human macrophages via mechanisms distinct from those previously identified in mouse macrophages.


Key Words: macrophages • nuclear receptors • lipopolysaccharide • reactive oxygen species




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Lakomy, C. Rebe, A.-L. Sberna, D. Masson, T. Gautier, A. Chevriaux, M. Raveneau, N. Ogier, A. T. Nguyen, P. Gambert, et al.
Liver X Receptor-Mediated Induction of Cholesteryl Ester Transfer Protein Expression Is Selectively Impaired in Inflammatory Macrophages
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1923 - 1929.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Wu, R. Yin, R. Ernest, Y. Li, O. Zhelyabovska, J. Luo, Y. Yang, and Q. Yang
Liver X receptors are negative regulators of cardiac hypertrophy via suppressing NF-{kappa}B signalling
Cardiovasc Res, October 1, 2009; 84(1): 119 - 126.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Rebe, M. Raveneau, A. Chevriaux, D. Lakomy, A.-L. Sberna, A. Costa, G. Bessede, A. Athias, E. Steinmetz, J. M. A. Lobaccaro, et al.
Induction of Transglutaminase 2 by a Liver X Receptor/Retinoic Acid Receptor {alpha} Pathway Increases the Clearance of Apoptotic Cells by Human Macrophages
Circ. Res., August 14, 2009; 105(4): 393 - 401.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Heine, A. Dahten, K. Hilt, D. Ernst, M. Milovanovic, B. Hartmann, and M. Worm
Liver X Receptors Control IgE Expression in B Cells
J. Immunol., May 1, 2009; 182(9): 5276 - 5282.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Fontaine, E. Rigamonti, B. Pourcet, H. Duez, C. Duhem, J.-C. Fruchart, G. Chinetti-Gbaguidi, and B. Staels
The Nuclear Receptor Rev-erb{alpha} Is a Liver X Receptor (LXR) Target Gene Driving a Negative Feedback Loop on Select LXR-Induced Pathways in Human Macrophages
Mol. Endocrinol., August 1, 2008; 22(8): 1797 - 1811.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E. Rigamonti, G. Chinetti-Gbaguidi, and B. Staels
Regulation of Macrophage Functions by PPAR-{alpha}, PPAR-{gamma}, and LXRs in Mice and Men
Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1050 - 1059.
[Abstract] [Full Text] [PDF]